共 96 条
[1]
Berry DA(2012)Multiplicities in cancer research: Ubiquitous and necessary evils J Natl Cancer Inst 104 1125-1133
[2]
Ioannidis JPA(2005)Why most published research findings are false PLoS Med 2 e124-16
[3]
Allegra CJ(2011)Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08 J Clin Oncol 29 11-663
[4]
Yothers G(1983)Discrete sequential boundaries for clinical trials Biometrika 70 659-2550
[5]
O’Connell MJ(2006)Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 2542-1544
[6]
Sharif S(2007)Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 J Clin Oncol 25 1539-2342
[7]
Petrelli NJ(2004)Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335-2064
[8]
Colangelo LH(2006)Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06 J Clin Oncol 24 2059-2204
[9]
Atkins JN(2007)Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 J Clin Oncol 25 2198-165
[10]
Seay TE(1988)Statistical analysis and the illusion of objectivity Am Sci 76 159-283